Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis

American Journal of Gastroenterology

Volumn 94, Issue 8, 1999, Pages 2193-2197

  Deschênes, Marc ^a   Villeneuve, Jean Pierre ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BACTERIAL INFECTION; BACTERIAL PERITONITIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM;

ADULT; AGED; BACTERIAL INFECTIONS; CROSS INFECTION; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; IMMUNE TOLERANCE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PERITONITIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033180281     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00349-4     Document Type: Article

References (36)

1. Grange JD, Amiot X. La prophylaxie des complications infectieuses par décontamination bactérienne digestive sélective chez les malades atteints de cirrhose. Gastroenterol Clin Biol 1992:16:692-700.
2. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993; 18:353-8.
3. Rimola A, Bory F, Teres J, et al. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal bleeding. Hepatology 1985;5:463-7.
4. Soriano G, Guamer C, Teixido M, et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology 1991 ; 100:477- 81.
5. Soriano G, Guarner C, Tomas A, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992;103:1267-72.
6. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800-9.
7. Rimola A, Soto R, Bory F, et al. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 1984;4:53-8.
8. Carey WD, Boayke A, Leatherman J. Spontaneous bacterial peritonitis: Clinical and laboratory features with reference to hospital-acquired cases. Am J Gastroenterol 1986;81:115661.
9. Pugh RM, Murray-Lyon IM, Dawson JL, et al. Transection of the esophagus for bleeding varices. Br J Surg 1973:60:646-9.
10. Wyke RJ. Problems of bacterial infection in patients with liver disease. Gut 1987;28:623-41.
11. Thomas HC, McSween RN, White RG. Role of the liver in controlling the immunogenicity of commensal bacteria in the gut. Lancet 1973;1:1288-91.
12. Whipple RL, Harris JE. E. coli septicemia in Laennec's cirrhosis of the liver. Ann Intern Med 1950;33:462-6.
13. Tisdale WA. Spontaneous colon bacillus bacteremia in Laennec's cirrhosis. Gastroenterology 1961;40:141-7.
14. Martin WJ, McHenry MC, Wellman WE, et al. Severe liver disease complicated by bacteremia. Arch Intern Med 1962;. 109:555-62.
15. Correia JP, Conn HO. Spontaneous bacterial peritonitis in cirrhosis: Endemic or epidemic? Med Clin North Am 1975; 59:963-1.
16. Rajkovic A, Williams R. Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology 1986;6:252-62.
17. Bereny MR, Straus B, Cruz D. In vitro and in vivo studies of cellular immunity in alcoholic cirrhosis. Am J Dig Dis 1974; 19:199-205.
18. DeMeo AM, Anderson BR. Defective chemotaxis associated with a serum inhibitor in cirrhotic patients. N Engl J Med 1972;286:735-740.
19. Potter BJ, Trueman AM, Jones EA. Serum complement in chronic liver disease. Gut 1973; 14:451-6.
20. Simberkoff MS, Boldover NH, Weiss G. Bactericidal and opsonic activity of cirrhotic ascites and non-ascitic peritoneal fluid. J Lab Clin Med 1978;91:831-9.
21. Wyke RJ, Rajkovic IA, Williams R. Impaired opsonization by serum from patients with chronic liver disease. Clin Exp Immunol 1983;51:91-8.
22. Akalin HE, Laleli Y, Teletar H. Bactericidal and opsonic activity of ascitic fluid from cirrhotic and non-cirrhotic patients. J Infect Dis 1983;147:1011-7.
23. Iber EL, Ker DMS, Dolle W, et al. Measurement of blood flow in collateral vessel of the portal vein: Preliminary result of a new method. J Clin Invest 1960;39:1201-7.
24. Martini GA, Phear EA, Ruebner B, et al. Bacterial content of small intestine in normal and cirrhotic subjects in relation to methionine toxicity. Clin Sci 1957;16:35-51.
25. Astaldi G, Strojelli E. Peroral biopsy of the intestinal mucosa in hepatic cirrhosis. Am J Dig Dis 1960;5:603-12.
26. Ruttenberg AM, Sonnenblick E, Koven I, et al. Comparative response of normal and cirrhotic rats to intravenously injected bacteria. Proc Soc Exp Biol Med 1959:101:279-81.
27. Graudal M, Milman M, Kirkegaard E, et al. Bacteremia in cirrhosis of the liver. Liver 1986;6:297-301.
28. Jones EA, Growley H, Sherlock S. Bacteremia in association with hepatocellular and hepatobiliary disease. Postgrad Med J 1967:43:7-11.
29. Barnes PF, Arevalo C, Chan LS, et al. A prospective evaluation of bacteremic patients with chronic liver disease. Hepatology 1988:8:1099-1103.
30. Sorrell WT, Quigley EMM, Jin G, et al. Bacterial translocation in the portal-hypertensive rats: Studies in basal conditions and on exposure to hemorrhagic shock. Gastroenterology 1993; 104:1722-6.
31. Pardy BJ, Spencer RC, Dudley HAF. Hepatic reticuloendothelial protection against bacteremia in experimental hemorrhagic shock. Surgery 1977:81:193-7.
32. Altura BM, Hershey SG. Sequential changes in reticuloendothelial system function after acute hemorrhage. Proc Soc Exp Biol 1972;139:935-9.
33. Bleichner G, Boulanger R, Squara P, et al. Frequency of infections in cirrhotic patients presenting with acute gastrointestinal hemorrhage. Br J Surg 1986:73:724-6.
34. Potsieter PD, Hammond JM. Prophylactic use of the new quinolones for prevention of nosocomial infection in the intensive care unit. Drugs 1995;49:86-91.
35. Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 1988:8:632-5.
36. Such J, Guamer C, Soriano G, et al. Selective intestinal decontamination increases serum and ascitic fluid C3 levels in cirrhosis. Hepatology 1990;12:1175-8.